A rare case of bronze diabetes in a patient with thalassemia


  • Karan V. Sharma GCS Medical College, Hospital and Research Centre Ahmedabad, Gujarat, India http://orcid.org/0000-0002-7969-381X
  • Parth B. Khandhedia GCS Medical College, Hospital and Research Centre Ahmedabad, Gujarat, India
  • Vijay H. Sharma Poonam Multispeciality Hospital, Ahmedabad, Gujarat, India




Bronze diabetes, Chelation therapy, Thalassemia major, Iron overload


Secondary haemochromatosis (also known as bronze diabetes) is a perilous medical condition that can occur as a complication of frequent blood transfusions. Thalassemia major which occurs due to a decrease in the beta globulin chain can lead to severe anemia, extramedullary hematopoiesis and splenomegaly. Because of this, the affected patients required continuous blood transfusions throughout their life and as a consequence, it may lead to iron overload. A 26-year-old male presented with a complaint of darkening skin, joint pain and fever. He was a known case of thalassemia major and was undergoing blood transfusions three times a week. Further laboratory findings revealed decreased hemoglobin, abnormal liver function tests and increased blood glucose levels. The patient was managed with IV insulin and chelation therapy. The patient responded to treatment and was better on subsequent follow-up. The diagnostic and therapeutic challenges along with the epidemiological data emphasize the need of raising the awareness of physicians to this devastating condition.


Diagnosis of thalassemia (adults and children). Available at: https://www.uptodate.com/contents/ diagnosis-of-thalassemia-adults-and-children. Accessed on 20 June 2021.

Brittenham GM. Iron-chelating therapy for transfusional iron overload. N Engl J Med. 2011; 364(2):146-56.

Barton JC, Acton RT, Leiendecker-Foster C, Lovato L, Adams PC, Eckfeldt JH, et al. Characteristics of participants with self-reported hemochromatosis or iron overload at HEIRS Study initial screening. Am J Hematol. 2008;83(2):126.

Brown K, Subramony C, May W, Megason G, Liu H, Bishop P, et al. Hepatic iron overload in children with sickle cell anemia on chronic transfusion therapy. J Pediatr Hematol Oncol. 2009;31(5):309-12.

Atmakusuma TD, Lubis AM. Correlation of serum ferritin and liver iron concentration with transient liver elastography in adult thalassemia intermedia patients with blood transfusion. J Blood Med. 2021;12:235-43.

Veríssimo MP de A, Loggetto SR, Fabron Junior A, Baldanzi GR, Hamerschlak N, Fernandes JL, et al. Brazilian Thalassemia Association protocol for iron chelation therapy inpatients under regular transfusion. Rev Bras Hematol Hemoter. 2013 Nov;35(6):428.

Akshatha LN, Shenoy MT, Yadav C, Rukmini MS, Kamath N. Bronze Diabetes. J Clin Diagn Res. 2015; 9(4):BD01.






Case Reports